Literature DB >> 16814865

Properties of the Group IV phospholipase A2 family.

Moumita Ghosh1, Dawn E Tucker, Scott A Burchett, Christina C Leslie.   

Abstract

The Group IV phospholipase A2 family is comprised of six intracellular enzymes commonly called cytosolic phospholipase A2 (cPLA2) alpha, cPLA2beta, cPLA2gamma, cPLA2delta, cPLA2epsilon and cPLA2zeta. They are most homologous to phospholipase A and phospholipase B/lysophospholipases of filamentous fungi particularly in regions containing conserved residues involved in catalysis. However, a number of other serine acylhydrolases (patatin, Group VI PLA2s, Pseudomonas aeruginosa ExoU and NTE) contain the Ser/Asp catalytic dyad characteristic of Group IV PLA2s, and recent structural analysis of patatin has confirmed its structural similarity to cPLA2alpha. A characteristic of all these serine acylhydrolases is their ability to carry out multiple reactions to varying degrees (PLA2, PLA1, lysophospholipase and transacylase activities). cPLA2alpha, the most extensively studied Group IV PLA2, is widely expressed in mammalian cells and mediates the production of functionally diverse lipid products in response to extracellular stimuli. It has PLA2 and lysophospholipase activities and is the only PLA2 that has specificity for phospholipid substrates containing arachidonic acid. Because of its role in initiating agonist-induced release of arachidonic acid for the production of eicosanoids, cPLA2alpha activation is important in regulating normal and pathological processes in a variety of tissues. Current information available about the biochemical properties and tissue distribution of other Group IV PLA2s suggests they may have distinct mechanisms of regulation and functional roles.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16814865     DOI: 10.1016/j.plipres.2006.05.003

Source DB:  PubMed          Journal:  Prog Lipid Res        ISSN: 0163-7827            Impact factor:   16.195


  150 in total

1.  cPLA2 regulates the expression of type I interferons and intracellular immunity to Chlamydia trachomatis.

Authors:  Mark J Vignola; David F Kashatus; Gregory A Taylor; Christopher M Counter; Raphael H Valdivia
Journal:  J Biol Chem       Date:  2010-05-07       Impact factor: 5.157

2.  MALDI imaging of lipid biochemistry in tissues by mass spectrometry.

Authors:  Karin A Zemski Berry; Joseph A Hankin; Robert M Barkley; Jeffrey M Spraggins; Richard M Caprioli; Robert C Murphy
Journal:  Chem Rev       Date:  2011-09-26       Impact factor: 60.622

3.  Prevention of Escherichia coli K1 penetration of the blood-brain barrier by counteracting the host cell receptor and signaling molecule involved in E. coli invasion of human brain microvascular endothelial cells.

Authors:  Longkun Zhu; Donna Pearce; Kwang Sik Kim
Journal:  Infect Immun       Date:  2010-06-01       Impact factor: 3.441

4.  Extracellular loops of the Eschericia coli outer membrane protein A contribute to the pathogenesis of meningitis.

Authors:  Ravi Maruvada; Kwang Sik Kim
Journal:  J Infect Dis       Date:  2011-01-01       Impact factor: 5.226

Review 5.  Role of cytosolic calcium-dependent phospholipase A2 in Alzheimer's disease pathogenesis.

Authors:  M T Gentile; M G Reccia; P P Sorrentino; E Vitale; G Sorrentino; A A Puca; L Colucci-D'Amato
Journal:  Mol Neurobiol       Date:  2012-05-31       Impact factor: 5.590

6.  PGE(2) is a UVR-inducible autocrine factor for human melanocytes that stimulates tyrosinase activation.

Authors:  Renny J Starner; Lindy McClelland; Zalfa Abdel-Malek; Alex Fricke; Glynis Scott
Journal:  Exp Dermatol       Date:  2010-05-25       Impact factor: 3.960

7.  Role of phosphorylation and basic residues in the catalytic domain of cytosolic phospholipase A2alpha in regulating interfacial kinetics and binding and cellular function.

Authors:  Dawn E Tucker; Moumita Ghosh; Farideh Ghomashchi; Robyn Loper; Saritha Suram; Bonnie St John; Milena Girotti; James G Bollinger; Michael H Gelb; Christina C Leslie
Journal:  J Biol Chem       Date:  2009-01-28       Impact factor: 5.157

Review 8.  Eicosanoid signalling pathways in the heart.

Authors:  Christopher M Jenkins; Ari Cedars; Richard W Gross
Journal:  Cardiovasc Res       Date:  2008-12-14       Impact factor: 10.787

9.  Arachidonic acid release mediated by OX1 orexin receptors.

Authors:  Pauli M Turunen; Marie E Ekholm; Pentti Somerharju; Jyrki P Kukkonen
Journal:  Br J Pharmacol       Date:  2009-12-04       Impact factor: 8.739

10.  Cysteinyl leukotrienes as novel host factors facilitating Cryptococcus neoformans penetration into the brain.

Authors:  Longkun Zhu; Ravi Maruvada; Adam Sapirstein; Marc Peters-Golden; Kwang Sik Kim
Journal:  Cell Microbiol       Date:  2016-09-25       Impact factor: 3.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.